Novartis faces Japan probe
January 10, 2014Sales and Marketing Diovan, Japan, Novartis
Novartis is under pressure in Japan where authorities are looking at the way the Swiss firm promoted its blood pressure …
PM Society Advertising awards finalists announced
January 9, 2014Medical Communications, Sales and Marketing London, advertising, pm awards
The finalists for the 2013 PM Society Advertising awards have been announced today as pharma and their med comms agencies …
Teva names new chief executive
January 9, 2014Manufacturing and Production, Research and Development, Sales and Marketing Levin, Teva, erez vigodman, generics
The world’s biggest generic drugmaker Teva has appointed the chief executive of the world’s biggest generic agrochemical company. Vigodman joins …
EMA to review daclatasvir
January 9, 2014Sales and Marketing BMS, EMA, daclatasvir, hep C
European regulators are to conduct a speedy investigation into one of Bristol-Myers Squibb’s investigational drugs for chronic hepatitis C virus …
Forest to buy Aptalis for $2.9 billion
January 9, 2014Sales and Marketing Forest, aptlias, canasa, maris
Forest Laboratories will spend around $2.9 billion to purchase Aptalis, a privately-held US firm specialising in treatments for gastrointestinal disorders …
Just:: hires managing director
January 9, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Just::, PR, comms
PR firm Just:: Health Communications has hired Kirsty Mearns as a managing director to lead its senior management team. She …
Cancer treatment Abraxane gets EU nod
January 9, 2014Sales and Marketing Abraxane, Cancer, Celgene, EU, pancreatic
Celgene’s cancer drug Abraxane has been approved by European regulators to treat patients with metastatic adenocarcinoma of the pancreas, or …
Imbruvica boost for Pharmacyclics
January 8, 2014Sales and Marketing Janssen, Pharmacyclics, imbruvica
Pharmacyclics and Janssen Biotech have received a huge boost as a late-stage trial of their first-in-class, oral blood cancer drug …
AstraZeneca strikes cancer vaccine pact
January 8, 2014Research and Development, Sales and Marketing AstraZeneca, Cancer, MedImmune, oncology
AstraZeneca’s biologics arm MedImmune has struck an oncology research deal with UK biotech company Immunocore. The deal, which could be …
SCM Pharma hires US-based manager
January 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing SCM Pharma, richards
UK Sterile manufacturing specialist SCM Pharma has appointed US-based business development manager Derek Richards. Richards will oversee the contract development …
AZ and Horizon in cancer tie-up
January 8, 2014Research and Development, Sales and Marketing AstraZeneca, Cancer, horizon, medimunne
AstraZeneca has signed a deal with British biotech firm Horizon Discovery to look at a number of genotypes to see …
US cancer research receives $540 million
January 7, 2014Research and Development, Sales and Marketing Cancer, US, licr, ludwig
Six facilities in the US have received a total of $540 million from the estate of an American businessman in …
Janssen bets on stem cells
January 7, 2014Research and Development, Sales and Marketing CDC, Janssen, Stem cells, cap, capricor
US biotech Capricor Therapeutics is being backed by Janssen Biotech to the tune of hundreds of millions of dollars to …
Pharma facility news in brief
January 7, 2014Manufacturing and Production manufacturing, pharma
GlaxoSmithKline has launched a new website and Twitter account to inform the public about progress with its £350 million ($574 …
GE makes $1 billion Thermo deal
January 7, 2014Sales and Marketing general electric, merger, thermo fisher
General Electric Company is to pay around $1.06 billion in a bid to boost its life sciences capability in pharma’s …
Healthcare Corporation of America names chief executive and chairman
January 7, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing healthcare corporation of america
The Healthcare Corporation of America has appointed Natasha Giordano as its chief executive and Yaron Eitan as chairman of the …
FDA and EMA team up for generic drug inspections
January 6, 2014Manufacturing and Production EMA, FDA, GMP, Taylor, manufacturing
The regulatory authorities in the US and EU have taken another step towards harmonisation by agreeing to pool their resources …
EMA identifies GMP transgressors in public database
January 6, 2014Manufacturing and Production Database, EMA, GDP, GMP
The European Medicines Agency has continued its march towards increased transparency by publishing – for the first time – the …
NHS patient data to be shared with researchers
January 6, 2014Medical Communications, Research and Development, Sales and Marketing NHS, data, online, transparency
NHS England will begin to gather patient data from GPs for the first time this spring to ‘improve care and …
GSK and Sanofi expand transparency
January 6, 2014Research and Development, Sales and Marketing GSK, Goldacre, Sanofi, alltrials, transparency
GlaxoSmithKline and Sanofi have announced separate moves which will shine greater light on both companies’ clinical trial data. GSK has …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
